gRNACRISPR/Cas9B

Ling Fei1, ShuangShuang Sun2, Qunling Yang1

  • 1Department of Liver Disease, Shanghai Public Health Clinical Center, Fudan University, 201508 Shanghai, China.

Discovery medicine
|June 26, 2024
PubMed
概括

双导引RNA (gRNA) CRISPR/Cas9疗法在抑制乙型肝炎病毒 (HBV) 复制和促进病毒清除方面显示出增强的疗效. 这种基因编辑方法为慢性HBV感染患者的功能治疗提供了潜在的潜力.